Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 151b (MIR151B) is a small, non-coding RNA molecule found in humans and classified in the family of microRNAs that regulate gene expression post-transcriptionally, primarily by binding to complementary sequences in mRNA targets. It has been identified as one of several miRNAs downregulated in T-cell acute lymphoblastic leukemia (T-ALL) in children, suggesting a potential role in the transcriptional profiling of hematologic malignancies. There are no well-established direct disease mechanisms, therapeutic agents, or pharmacological interventions specifically targeting miR-151b. Its primary recognized role is as a biomarker in high-throughput expression assays meant for distinguishing leukemia subtypes in research settings[1][3].
Not established for drugs; theoretical mechanism would involve base-pairing with mRNA and repression or degradation (if antagonized, would relieve this repression)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 151b (MIR151B).